Liraglutide, illustration

Liraglutide, illustration

C028/0299 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 74.2MB

Downloadable file size: 1.1MB

Price image Pricing

Please login to use the price calculator


Caption: A molecular model of liraglutide, a glucagon-like peptide-1 (GLP-1) agonist used to treat type 2 diabetes. In order to reduce hyperglycemia (high blood sugar) after a meal, liraglutide increases insulin secretion, delays gastric emptying and suppresses glucagon secretion. Liraglutide is also known to decrease appetite to help maintain body weight, lower blood triglyceride levels, as well as inhibit the death and stimulate the regeneration of beta cells in the pancreas. Atoms are coloured dark gray (carbon), light gray (hydrogen), blue (nitrogen) and red (oxygen).

Release details: Model release not required. Property release not required.

Keywords: 3d, 3d illustration, 3d model, blood glucose, chemistry, diabetes, drug, glp, glucagon-like peptide, hyperglycemia, liraglutide, medication, molecular, molecule, pharmaceutical, pharmacology, victoza

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.